Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review

Int J Biol Macromol. 2023 Aug 1:245:125515. doi: 10.1016/j.ijbiomac.2023.125515. Epub 2023 Jun 21.

Abstract

Since May 2022, the mpox virus (MPXV) has spread worldwide and become a potential threat to global public health. Vaccines are important tools for preventing MPXV transmission and infection in the population. However, there are still no available potent and applicable vaccines specifically for MPXV. Herein, we highlight several potential vaccine targets for MPVX and emphasize potent immunogens, such as M1R, E8L, H3L, A29L, A35R, and B6R proteins. These proteins can be integrated into diverse vaccine platforms to elicit powerful B-cell and T-cell responses, thereby providing protective immunity against MPXV infection. Overall, research on the MPXV vaccine targets would provide valuable information for developing timely effective MPXV-specific vaccines.

Keywords: Epitopes; MPXV; Platforms; Targets; Vaccine.

Publication types

  • Review

MeSH terms

  • B-Lymphocytes
  • Monkeypox virus
  • Viral Vaccines*

Substances

  • Viral Vaccines